Page 1 of Clinical Trials for long-acting risperidone, 71 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Last Updated: July 6, 2010
Condition(s): Schizophrenia, Catatonic; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Schizophrenia; Psychotic Disorders
2
Completed
A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
Last Updated: April 26, 2010
Condition(s): Schizophrenia
3
Completed
A Study of the Effectiveness and Safety of Long Acting Risperidone in Patients With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
Last Updated: May 24, 2012
Condition(s): Risperdal Consta; Schizophrenia; Schizoaffective Disorders
4
Completed
A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.
Last Updated: May 16, 2011
Condition(s): Schizophrenia
5
Completed
Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection
Last Updated: May 17, 2011
Condition(s): Schizophrenia; Psychotic Disorders
6
Completed
Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
Last Updated: April 2, 2012
Condition(s): Schizophrenia
7
Completed
A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
Last Updated: October 3, 2008
Condition(s): Schizophrenia
8
Completed
A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: May 17, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder
9
Active, not recruiting
PREvent First Episode Relapse (PREFER)
Last Updated: March 28, 2008
Condition(s): Schizophrenia
10
Completed
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
Last Updated: June 23, 2011
Condition(s): Schizophrenia; Tranquilizing Agents; Mental Disorders; Therapeutic Uses; Physiological Effects of Drugs; Psychotropic Drugs; Antipsychotic Agents
11
Completed
Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
Last Updated: May 16, 2011
Condition(s): Schizophrenia; Psychotic Disorders
12
Completed
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia
Last Updated: June 6, 2011
Condition(s): Schizophrenia
13
Completed
A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: November 18, 2010
Condition(s): Schizophrenia
14
Suspended
Optimizing Response in Psychosis Study
Last Updated: May 24, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Psychotic Disorder Not Otherwise Specified
15
Completed
A Study of the Efficacy, Safety, and Quality of Life of Patients With Schizophrenia Receiving Treatment With a Long-acting Injectable Formulation of Risperidone
Last Updated: June 17, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder
16
Completed
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
Last Updated: March 3, 2011
Condition(s): Schizophrenia; Schizophreniform Disorders; Schizoaffective Disorder
17
Completed
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: May 17, 2011
Condition(s): Schizophrenia; Psychotic Disorders
18
Completed
A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
Last Updated: April 22, 2010
Condition(s): Schizophrenia; Psychotic Disorders
19
Completed
A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: June 6, 2011
Condition(s): Schizophrenia; Psychotic Disorders
20
Completed
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Last Updated: October 25, 2011
Condition(s): Schizophrenia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=long-acting+risperidone

Page 1 of Clinical Trials for long-acting risperidone, 71 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About